No Obamacare Bailout: Why CIGNA Corporation Lost Huge Today

The $21 billion managed-care company Cigna fell a surprising 10% today, due to shockingly poor fourth-quarter earnings. While revenue did beat expectations, looking at the bottom line, the company's earnings actually fell, with net income down $45 million, to $361 million. Even after backing out one-time items, earnings per share still fell, down from $1.57 per share, to $1.39, which was a full $0.10  a share lower than Wall Street was predicting. Even worse, the company indicated 2014 would be a tough year, kicked off by a likely earnings decline in the first quarter.

However, one of the biggest points of curiosity for investors is how Cigna, and other managed care companies, will be affected by the new Affordable Care Act legislation, also known as Obamacare. In this video, Motley Fool health-care analyst David Williamson gives investors a breakdown of how Cigna has been affected so far, which insurers are benefiting from the new legislation, and how Medicare Advantage and its new reimbursement rates could hit these companies hard going forward.

So how will Obamacare ultimately impact your investments?
Obamacare seems complex, but it doesn't have to be. In only minutes, you can learn the critical facts you need to know in a special free report called, "Everything You Need to Know About Obamacare." This FREE guide contains the key information and money-making advice that every American must know. Please click here to access your free copy.

The article No Obamacare Bailout: Why CIGNA Corporation Lost Huge Today originally appeared on

David Williamson has no position in any stocks mentioned. The Motley Fool recommends WellPoint. The Motley Fool owns shares of WellPoint. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2014 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Read Full Story